BACKGROUND: Sex hormones are known to have significant effects on the pathophysiology of cardiovascular disease. OBJECTIVE: The purpose of this study was to study the association between sex hormone levels and sudden cardiac arrest (SCA). METHODS: In the ongoing Oregon Sudden Unexpected Death Study (catchment population approximately 1 million), cases of SCA were compared with matched controls. Testosterone and estradiol levels were measured from blood samples drawn at the time of the SCA event in cases and during a routine visit in controls. RESULTS: Among cases (n = 149, age 64.1 ± 11.7 years, 73.2% male), compared to controls (n = 149, 64.2 ± 11.6 years, 72.5% male), median testosterone levels were significantly lower in males (4.4 vs 5.4 ng/mL, P = .01). Median estradiol levels were higher in male (68 vs 52 pg/mL, P <.001) and female cases (54 vs 36 pg/mL, P <.001). In multivariate analysis, higher testosterone levels were associated with lower SCA odds only in males (odds ratio [OR] 0.75, 95% confidence interval [CI] 0.58-0.96, P = .02). Higher estradiol levels were associated with higher SCA odds in both males (OR 2.0, 95% CI 1.5-2.6, P <.001) and females (OR 3.5, 95% CI 1.9-6.4, P <.001). A higher testosterone/estrogen ratio was associated with lower SCA odds in males only (OR 0.5, 95% CI 0.4-0.7, P <.001). In a canine model of SCA, plasma testosterone levels were not significantly altered by the cardiac arrest event. CONCLUSION: We observed significant differences in sex hormone levels in patients who suffered SCA, with potential mechanistic implications. The role of sex hormones in the genesis of fatal ventricular arrhythmias warrants further exploration.
BACKGROUND: Sex hormones are known to have significant effects on the pathophysiology of cardiovascular disease. OBJECTIVE: The purpose of this study was to study the association between sex hormone levels and sudden cardiac arrest (SCA). METHODS: In the ongoing Oregon Sudden Unexpected Death Study (catchment population approximately 1 million), cases of SCA were compared with matched controls. Testosterone and estradiol levels were measured from blood samples drawn at the time of the SCA event in cases and during a routine visit in controls. RESULTS: Among cases (n = 149, age 64.1 ± 11.7 years, 73.2% male), compared to controls (n = 149, 64.2 ± 11.6 years, 72.5% male), median testosterone levels were significantly lower in males (4.4 vs 5.4 ng/mL, P = .01). Median estradiol levels were higher in male (68 vs 52 pg/mL, P <.001) and female cases (54 vs 36 pg/mL, P <.001). In multivariate analysis, higher testosterone levels were associated with lower SCA odds only in males (odds ratio [OR] 0.75, 95% confidence interval [CI] 0.58-0.96, P = .02). Higher estradiol levels were associated with higher SCA odds in both males (OR 2.0, 95% CI 1.5-2.6, P <.001) and females (OR 3.5, 95% CI 1.9-6.4, P <.001). A higher testosterone/estrogen ratio was associated with lower SCA odds in males only (OR 0.5, 95% CI 0.4-0.7, P <.001). In a canine model of SCA, plasma testosterone levels were not significantly altered by the cardiac arrest event. CONCLUSION: We observed significant differences in sex hormone levels in patients who suffered SCA, with potential mechanistic implications. The role of sex hormones in the genesis of fatal ventricular arrhythmias warrants further exploration.
Authors: M Juhani Junttila; Jani T Tikkanen; Kimmo Porthan; Lasse Oikarinen; Antti Jula; Tuomas Kenttä; Veikko Salomaa; Heikki V Huikuri Journal: J Am Coll Cardiol Date: 2013-07-31 Impact factor: 24.094
Authors: A Elisabeth Hak; Jacqueline C M Witteman; Frank H de Jong; Mirjam I Geerlings; Albert Hofman; Huibert A P Pols Journal: J Clin Endocrinol Metab Date: 2002-08 Impact factor: 5.958
Authors: Christine M Albert; Claudia U Chae; Francine Grodstein; Lynda M Rose; Kathryn M Rexrode; Jeremy N Ruskin; Meir J Stampfer; JoAnn E Manson Journal: Circulation Date: 2003-04-14 Impact factor: 29.690
Authors: Sumeet S Chugh; Jonathan Jui; Karen Gunson; Eric C Stecker; Benjamin T John; Barbara Thompson; Nasreen Ilias; Catherine Vickers; Vivek Dogra; Mohamud Daya; Jack Kron; Zhi-Jie Zheng; George Mensah; John McAnulty Journal: J Am Coll Cardiol Date: 2004-09-15 Impact factor: 24.094
Authors: JoAnn E Manson; Judith Hsia; Karen C Johnson; Jacques E Rossouw; Annlouise R Assaf; Norman L Lasser; Maurizio Trevisan; Henry R Black; Susan R Heckbert; Robert Detrano; Ora L Strickland; Nathan D Wong; John R Crouse; Evan Stein; Mary Cushman Journal: N Engl J Med Date: 2003-08-07 Impact factor: 91.245
Authors: Deniz Akdis; Ardan M Saguner; Khooshbu Shah; Chuanyu Wei; Argelia Medeiros-Domingo; Arnold von Eckardstein; Thomas F Lüscher; Corinna Brunckhorst; H S Vincent Chen; Firat Duru Journal: Eur Heart J Date: 2017-05-14 Impact factor: 29.983
Authors: P G Hiremath; F Bhondoekhan; S A Haberlen; H Ashikaga; F J Palella; G D'Souza; M J Budoff; L A Kingsley; A S Dobs; W S Post; E Z Soliman; T T Brown; K C Wu Journal: HIV Med Date: 2020-12-03 Impact factor: 3.180
Authors: Adeline Boileau; Antonio Salgado Somoza; Josef Dankiewicz; Pascal Stammet; Patrik Gilje; David Erlinge; Christian Hassager; Matthew P Wise; Michael Kuiper; Hans Friberg; Niklas Nielsen; Yvan Devaux Journal: Dis Markers Date: 2019-06-02 Impact factor: 3.434
Authors: G Piccirillo; F Moscucci; R Pofi; G D'Alessandro; M Minnetti; A M Isidori; D Francomano; A Lenzi; P E Puddu; J Alexandre; D Magrì; A Aversa Journal: J Endocrinol Invest Date: 2019-03-05 Impact factor: 4.256
Authors: Ahmad Haider; Aksam Yassin; Karim Sultan Haider; Gheorghe Doros; Farid Saad; Giuseppe Mc Rosano Journal: Vasc Health Risk Manag Date: 2016-06-14